Visible Synthetic-Cannabinoid Convulsions Did Not Always Match EEG Seizures in Mice

Visible convulsive behavior and an electrographic seizure are not identical observations. A mouse experiment with several synthetic cannabinoid receptor agonists found convulsions without accompanying EEG seizures under its recording conditions.

The drugs were specific synthetic agonists

The study investigated AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA and JWH-018. These are not interchangeable with THC or plant cannabis. Researchers assessed observed behavior, EEG measures and video, with pentylenetetrazole used in the broader experimental comparisons.

Antagonist and pretreatment findings differed

The abstract reports that rimonabant blocked convulsive effects of selected compounds, consistent with CB1 receptor involvement. Diazepam did not block those effects under the tested pretreatment conditions. Repeated administration produced partial tolerance to some convulsive effects without cross-tolerance to pentylenetetrazole convulsions.

An EEG-negative result has limits

The result concerns the drugs, doses, animals and measurements actually studied. It does not establish that every synthetic-cannabinoid event in a person lacks an electrographic seizure, nor that visible convulsions are harmless. It also cannot establish treatment failure or dictate emergency treatment in humans.

For toxicology testimony, distinguish a witnessed movement description from a neurological diagnosis and from an identified chemical exposure. The name of a drug class alone does not supply the missing clinical evidence. This research illustrates why behavior, electrophysiology and receptor-mechanism experiments should be reported separately rather than collapsed into a single claim about cannabis and seizures.

Related: interpreting cannabis tolerance claims.

Research cited

Wilson CD; Zheng F; Fantegrossi WE. Convulsant doses of abused synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA and JWH-018 do not elicit electroencephalographic (EEG) seizures in male mice. Psychopharmacology (2022). doi:10.1007/s00213-022-06205-6. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Cannabinoid Effects on Habit Memory Should Not Be Relabeled as Better Memory Overall

A 2015 review distinguished dorsal-striatal habit or stimulus–response memory from other memory systems. A finding of stronger habitual responding does not establish a general cognitive benefit. The reviewed tasks measured a particular learning process The source discussed maze studies, genetic manipulations and human cannabis-user observations. These approaches assess different pieces…

Spread the love

Read Article: Cannabinoid Effects on Habit Memory Should Not Be Relabeled as Better Memory Overall

A Human Tolerance Review Found Different Degrees of Adaptation Across Cognitive and Cardiac Outcomes

A 2018 systematic review found evidence that tolerance varied across human response domains. Its synthesis described stronger cognitive adaptation in some studies than attenuation of intoxicating, psychotomimetic or cardiac effects. The evidence included two comparison types Some studies compared people with different cannabis-use histories; others examined repeated administration. A between-group…

Spread the love

Read Article: A Human Tolerance Review Found Different Degrees of Adaptation Across Cognitive and Cardiac Outcomes

Functional Driving Tests Need Validation for the Claim They Make, Even When Concentration Tests Are Limited

A 2019 perspective reviewed limitations of concentration-based and functional approaches to cannabis-impaired driving. Weakness in one approach does not automatically validate the other for every intended inference. The methods address different observations A concentration test measures a chemical in its specimen, while a functional task measures performance under test conditions….

Spread the love

Read Article: Functional Driving Tests Need Validation for the Claim They Make, Even When Concentration Tests Are Limited

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us